🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
PF-05180999 is a phosphodiesterase-2 inhibitor that is hypothesized to be a...
Status
Terminated
Location
Pfizer Investigational Site
Start Date
2014-01
Trial ID
NCT01981499
Treatments Being Tested
PF-05180999 is a novel phosphodiesterase-2 (PDE2) inhibitor. The purpose of...
Status
Withdrawn
Location
Multiple Locations
Start Date
2014-06
Trial ID
NCT01981486
Treatments Being Tested
The purpose of this study is to determine the safety, tolerability, and pha...
Status
Completed
Location
Pfizer Investigational Site
Start Date
2011-08
Trial ID
NCT01429740
Treatments Being Tested
The purpose of this study is to assess the bioavailability, safety, and tol...
Status
Completed
Location
Pfizer Investigational Site
Start Date
2012-01
Trial ID
NCT01530529
Treatments Being Tested